Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Augtyro (repotrectinib)
.
Show all posts
Showing posts with label
Augtyro (repotrectinib)
.
Show all posts
Monday, August 12, 2024
FDA Approves Augtyro (repotrectinib) for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)
›
Bristol Myers Squibb (NYSE: BMY) announced the U.S. Food and Drug Administration (FDA) approval of Augtyro (repotrectinib) for the treatme...
›
Home
View web version
